{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T15:45:57Z","timestamp":1793202357769,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,16]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Danon disease (DD) is an X-linked lysosomal storage disorder caused by\n                      <jats:italic toggle=\"yes\">LAMP2<\/jats:italic>\n                      variants, with males presenting more severe phenotypes. However, evidence for genotype-phenotype correlation remains limited. This study reports 2 male DD patients with distinct\n                      <jats:italic toggle=\"yes\">LAMP2<\/jats:italic>\n                      mutations to clarify mutation-specific prognostic differences.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 15-year-old male: chest tightness and palpitations, creatine kinase (CK) 3867 U\/L, and hypertrophic cardiomyopathy. A 12-year-old male: exertional dyspnea and syncope, left ventricular ejection fraction 36%, left ventricular thrombus, and CK 5210 U\/L.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      Both were diagnosed with DD via genetic testing: the 15-year-old had a\n                      <jats:italic toggle=\"yes\">LAMP2<\/jats:italic>\n                      IVS6\u2009+\u20091G &gt; T splice mutation, and the 12-year-old carried a\n                      <jats:italic toggle=\"yes\">LAMP2<\/jats:italic>\n                      exon 1 deletion.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The 15-year-old underwent heart transplantation followed by immunosuppressive therapy. The 12-year-old received only symptomatic treatment without transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The 15-year-old had normal cardiac function and normalized CK levels during 24-month posttransplant follow-up. The 12-year-old died of heart failure 8 months after diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">LAMP2<\/jats:italic>\n                      mutation types correlate with DD severity. Heart transplantation improves prognosis in severe cases, emphasizing the importance of early diagnosis and intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046993","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:08Z","timestamp":1768849268000},"page":"e46993","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Danon disease: Two case reports and literature review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9812-4823","authenticated-orcid":false,"given":"Kun","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Neurology, Zibo Central Hospital, Zibo City, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingnan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Badou Health Center, Zibo City, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Shandong Key Laboratory of Mitochondrial Medicine and Rare Diseases, Research Institute of Neuromuscular and Neurodegenerative Diseases, Qilu Hospital of Shandong University, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0362-7493","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zibo Central Hospital, Zibo City, Shandong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-015-1385-4","article-title":"Danon disease: a phenotypic expression of LAMP-2 deficiency.","volume":"129","author":"Endo","year":"2015","journal-title":"Acta Neuropathol"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/GIM.0b013e31820ad795","article-title":"Natural history of Danon disease.","volume":"13","author":"Boucek","year":"2011","journal-title":"Genet Med"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/nan.12587","article-title":"Review: Danon disease: review of natural history and recent advances.","volume":"46","author":"Cenacchi","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jacc.2023.08.014","article-title":"International consensus on differential diagnosis and management of patients with Danon disease: JACC State-of-the-Art Review.","volume":"82","author":"Hong","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijcard.2019.01.020","article-title":"Danon disease: gender differences in presentation and outcomes.","volume":"286","author":"Brambatti","year":"2019","journal-title":"Int J Cardiol"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2353\/ajpath.2006.050646","article-title":"Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease.","volume":"168","author":"Fanin","year":"2006","journal-title":"Am J Pathol"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0960-8966(02)00179-7","article-title":"Danon\u2019s disease (X-linked vacuolar cardiomyopathy and myopathy): a case with a novel Lamp-2 gene mutation.","volume":"12","author":"Lacoste-Collin","year":"2002","journal-title":"Neuromusc Disord"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children.","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"key":"R9-20260119","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.tcm.2021.11.007","article-title":"Editorial commentary: highlighting the ray of hope in Danon disease research after 40 years.","volume":"33","author":"Sugie","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy.","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.3390\/ijms19113507","article-title":"A nationwide survey on Danon disease in Japan.","volume":"19","author":"Sugie","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"eaax1744","DOI":"10.1126\/scitranslmed.aax1744","article-title":"Systemic AAV9.LAMP2B injection reverses metabolic and physiologic multiorgan dysfunction in a murine model of Danon disease.","volume":"12","author":"Manso","year":"2020","journal-title":"Sci Transl Med"},{"key":"R13-20260119","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1073\/pnas.1808618116","article-title":"LAMP-2B regulates human cardiomyocyte function by mediating autophagosome-lysosome fusion.","volume":"116","author":"Chi","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cge.12724","article-title":"The c.65-2A>G splice site mutation is associated with a mild phenotype in Danon disease due to the transcription of normal LAMP2 mRNA.","volume":"90","author":"Cetin","year":"2016","journal-title":"Clin Genet"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease).","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.nmd.2015.03.005","article-title":"Early onset cardiomyopathy in females with Danon disease.","volume":"25","author":"Hedberg Oldfors","year":"2015","journal-title":"Neuromusc Disord"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1253\/circj.CJ-08-0241","article-title":"Novel LAMP-2 mutation in a family with Danon disease presenting with hypertrophic cardiomyopathy.","volume":"73","author":"Dougu","year":"2009","journal-title":"Circ J"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/CIRCGENETICS.109.901785","article-title":"LAMP2 microdeletions in patients with Danon disease.","volume":"3","author":"Yang","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMoa2412392","article-title":"Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease.","volume":"392","author":"Greenberg","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:01:11Z","timestamp":1768849271000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046993","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2025-05-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}